Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lode

Showing results (281-290 of 369) with videos related to

Pageof 37
Sort By:
Journal of Chemotherapy (Florence, Italy)|August 19, 2000
Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study groupT File, B Schlemmer, J Garau, et al.
Deutsche Medizinische Wochenschrift (1946)|April 22, 1977
[A multi-centre study of reproterol, a bronchodilator (author's transl)]D Nolte, G Galgóczy, H Lode, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1983
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactamB Kemmerich, H Lode, G Belmega, et al.
Pneumologie (Stuttgart, Germany)|February 1, 1990
[Value of diagnostic procedures in fiberoptic bronchoscopy of pulmonary infections]D Mainz, N Mülleneisen, G Höffken, et al.
The European Respiratory Journal|April 1, 1992
Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokersT Schaberg, H Haller, M Rau, et al.
Schriftenreihe Des Vereins Fur Wasser-, Boden- Und Lufthygiene|January 1, 1987
[Clinical aspects and prognosis of Legionella infections]H Lode, H Grothe, H Schäfer, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
Multiple dose pharmacokinetics and therapeutic results with ceftazidimeH Warns, H Lode, C M Harnoss, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1989
Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acidK M Deppermann, H Lode, G Höffken, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adultsT M File, H Lode, H Kurz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 29, 2004
A randomised, double-blind, double-dummy comparative study of gatifloxacin with clarithromycin in the treatment of community-acquired pneumoniaH Lode, T Aronkyto, A G Chuchalin, et al.
Pageof 37

Showing results (281-290 of 369) with videos related to

Sort By:
Pageof 37
Journal of Chemotherapy (Florence, Italy)|August 19, 2000
Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study groupT File, B Schlemmer, J Garau, et al.
Deutsche Medizinische Wochenschrift (1946)|April 22, 1977
[A multi-centre study of reproterol, a bronchodilator (author's transl)]D Nolte, G Galgóczy, H Lode, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1983
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactamB Kemmerich, H Lode, G Belmega, et al.
Pneumologie (Stuttgart, Germany)|February 1, 1990
[Value of diagnostic procedures in fiberoptic bronchoscopy of pulmonary infections]D Mainz, N Mülleneisen, G Höffken, et al.
The European Respiratory Journal|April 1, 1992
Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokersT Schaberg, H Haller, M Rau, et al.
Schriftenreihe Des Vereins Fur Wasser-, Boden- Und Lufthygiene|January 1, 1987
[Clinical aspects and prognosis of Legionella infections]H Lode, H Grothe, H Schäfer, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
Multiple dose pharmacokinetics and therapeutic results with ceftazidimeH Warns, H Lode, C M Harnoss, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1989
Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acidK M Deppermann, H Lode, G Höffken, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adultsT M File, H Lode, H Kurz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 29, 2004
A randomised, double-blind, double-dummy comparative study of gatifloxacin with clarithromycin in the treatment of community-acquired pneumoniaH Lode, T Aronkyto, A G Chuchalin, et al.
Pageof 37